World health

Biotechnology, Cardiology, Diabetes, Diet, Featured, Longevity, Metabolic syndrome, World health
Lipodomic analysis identifies new lipid biomarkers for heart disease and type 2 diabetes

Researches from Deutsches Zentrum fuer Diabetesforschung (DZD), have identified new lipid biomarkers for CVD and T2D using lipodomic analysis. The team also found that increasing unsaturated fatty acid intake reduced

Cancer, Featured, Immunology, Pollution, World health
Mechanism identified showing how air pollution affects lung tissue

Researchers at Nanjing University have identified a mechanism by which air pollutants affect the structure of lung tissue and increase cancer risk. According to a research published today in eLife,

Cancer, Diabetes, Diet, Featured, Metabolic syndrome, Neuroscience, Obesity, World health
Yale researchers uncover key regulator of weight-gain suggesting a treatment target for metabolic disorders

A Yale research team found that a protein called, augmentor-alpha, is a key regulator of body weight in mice. (Picture: Obese mice (right) and normal-sized mice (left) in a study

Alzheimer's disease, Featured, Longevity, Neurocognitive disorders, Neuroscience, World health
Late-life alcohol abuse shown to be a possible symptom of dementia

People over 40 years old who develop alcohol abuse behaviors may be doing so in response to underlying brain disorders, such as early-onset dementia. According to a new study, adults

Biotechnology, Med Lifestyle, Medical News, World health
New decision support system reduced pneumonia mortality rate by 38%

Intermountain Healthcare researchers have demonstrated the clinical effectiveness of an electronic decision support system (eNPa) for patients with pneumonia. According to a new study by researchers at Intermountain Healthcare in

Alzheimer's disease, Biotechnology, Genetics, Longevity, Med Lifestyle, Medical News, Neurocognitive disorders, Neuroscience, World health
Blood test that identifies risk of Alzheimer’s disease shown to be highly accurate in large study

Researchers from Washington University School of Medicine in St. Louis have developed a highly reliable blood test for identifying Alzheimer’s disease, which uses the biomarkers amyloid beta proteins Aβ42 and